These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 22956138)

  • 1. Use of a fluorescent ATP analog to probe the allosteric conformational change in the active site of the protein kinase PDK1.
    Hindie V; Lopez-Garcia LA; Biondi RM
    Methods Mol Biol; 2012; 928():133-41. PubMed ID: 22956138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
    Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
    Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments.
    Stockman BJ; Kothe M; Kohls D; Weibley L; Connolly BJ; Sheils AL; Cao Q; Cheng AC; Yang L; Kamath AV; Ding YH; Charlton ME
    Chem Biol Drug Des; 2009 Feb; 73(2):179-88. PubMed ID: 19207420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.
    Stroba A; Schaeffer F; Hindie V; Lopez-Garcia L; Adrian I; Fröhner W; Hartmann RW; Biondi RM; Engel M
    J Med Chem; 2009 Aug; 52(15):4683-93. PubMed ID: 19606904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
    Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
    Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular insights into the regulatory landscape of PKC-related kinase-2 (PRK2/PKN2) using targeted small compounds.
    Gross LZF; Winkel AF; Galceran F; Schulze JO; Fröhner W; Cämmerer S; Zeuzem S; Engel M; Leroux AE; Biondi RM
    J Biol Chem; 2024 Aug; 300(8):107550. PubMed ID: 39002682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.
    Biondi RM; Komander D; Thomas CC; Lizcano JM; Deak M; Alessi DR; van Aalten DM
    EMBO J; 2002 Aug; 21(16):4219-28. PubMed ID: 12169624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept.
    Wilhelm A; Lopez-Garcia LA; Busschots K; Fröhner W; Maurer F; Boettcher S; Zhang H; Schulze JO; Biondi RM; Engel M
    J Med Chem; 2012 Nov; 55(22):9817-30. PubMed ID: 23106316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1.
    Wei L; Gao X; Warne R; Hao X; Bussiere D; Gu XJ; Uno T; Liu Y
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3897-902. PubMed ID: 20627557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.
    Engel M; Hindie V; Lopez-Garcia LA; Stroba A; Schaeffer F; Adrian I; Imig J; Idrissova L; Nastainczyk W; Zeuzem S; Alzari PM; Hartmann RW; Piiper A; Biondi RM
    EMBO J; 2006 Nov; 25(23):5469-80. PubMed ID: 17110931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocket.
    Lopez-Garcia LA; Schulze JO; Fröhner W; Zhang H; Süss E; Weber N; Navratil J; Amon S; Hindie V; Zeuzem S; Jørgensen TJ; Alzari PM; Neimanis S; Engel M; Biondi RM
    Chem Biol; 2011 Nov; 18(11):1463-73. PubMed ID: 22118680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA.
    Biondi RM; Cheung PC; Casamayor A; Deak M; Currie RA; Alessi DR
    EMBO J; 2000 Mar; 19(5):979-88. PubMed ID: 10698939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGC kinases, mechanisms of regulation ‎and innovative drug development.
    Leroux AE; Schulze JO; Biondi RM
    Semin Cancer Biol; 2018 Feb; 48():1-17. PubMed ID: 28591657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ.
    Fröhner W; Lopez-Garcia LA; Neimanis S; Weber N; Navratil J; Maurer F; Stroba A; Zhang H; Biondi RM; Engel M
    J Med Chem; 2011 Oct; 54(19):6714-23. PubMed ID: 21863889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.
    Hindie V; Stroba A; Zhang H; Lopez-Garcia LA; Idrissova L; Zeuzem S; Hirschberg D; Schaeffer F; Jørgensen TJ; Engel M; Alzari PM; Biondi RM
    Nat Chem Biol; 2009 Oct; 5(10):758-64. PubMed ID: 19718043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1.
    Xu X; Chen Y; Fu Q; Ni D; Zhang J; Li X; Lu S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):361-374. PubMed ID: 30734603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.
    Rettenmaier TJ; Sadowsky JD; Thomsen ND; Chen SC; Doak AK; Arkin MR; Wells JA
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18590-5. PubMed ID: 25518860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex.
    Jeffrey PD; Russo AA; Polyak K; Gibbs E; Hurwitz J; Massagué J; Pavletich NP
    Nature; 1995 Jul; 376(6538):313-20. PubMed ID: 7630397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric Regulation of Protein Kinases Downstream of PI3-Kinase Signalling.
    Leroux AE; Gross LZF; Sacerdoti M; Biondi RM
    Adv Exp Med Biol; 2019; 1163():279-311. PubMed ID: 31707708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a fluorescence polarization bead-based coupled assay to target different activity/conformation states of a protein kinase.
    Lu Z; Yin Z; James L; Syto R; Stafford JM; Koseoglu S; Mayhood T; Myers J; Windsor W; Kirschmeier P; Samatar AA; Malcolm B; Turek-Etienne TC; Kumar CC
    J Biomol Screen; 2004 Jun; 9(4):309-21. PubMed ID: 15191648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.